Industry
BELL Therapeutics Inc.
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
3(100.0%)
3Total
N/A(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT07295431Not ApplicableNot Yet Recruiting
Sleep Efficacy Randomized Evaluation of a Novel Digital Therapeutic for Insomnia
Role: lead
NCT07297524Not ApplicableNot Yet Recruiting
CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users
Role: collaborator
NCT07266415Not ApplicableActive Not Recruiting
Study for Pregnant Women With Insomnia Using Sleep Inducing Digital Sound Application
Role: collaborator
All 3 trials loaded